Ulcerative colitis (subacute manifestations) - infliximab
Infliximab for subacute manifestations of ulcerative colitis
Summary
Infliximab is not recommended for people with subacute, moderately to severely active ulcerative colitis. Subacute ulcerative colitis is defined as ulcerative colitis that would normally be managed without needing to stay in hospital overnight or having urgent surgery.
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in February 2011
About this guidance
Technology appraisals TA140
Issued: April 2008
How this guidance was produced